[1]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
DOI=10.1038/349614a0; PubMed=1847994 [NCBI, ExPASy, EBI, Israel, Japan]
Gerard N.P.,
Gerard C.;
"The chemotactic receptor for human C5a anaphylatoxin.";
Nature 349:614-617(1991).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1021/bi00226a002; PubMed=2007135 [NCBI, ExPASy, EBI, Israel, Japan]
Boulay F.,
Mery L.,
Tardif M.,
Brouchon L.,
Vignais P.;
"Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells.";
Biochemistry 30:2993-2999(1991).
|
[3]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Kopatz S.A.,
Aronstam R.S.,
Sharma S.V.;
"cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org).";
Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Kalnine N.,
Chen X.,
Rolfs A.,
Halleck A.,
Hines L.,
Eisenstein S.,
Koundinya M.,
Raphael J.,
Moreira D.,
Kelley T.,
LaBaer J.,
Lin Y.,
Phelan M.,
Farmer A.;
"Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[6]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-3.
DOI=10.1021/bi00056a007; PubMed=8383526 [NCBI, ExPASy, EBI, Israel, Japan]
Gerard N.P.,
Bao L.,
Xiao-Ping H.,
Eddy R.L. Jr.,
Shows T.B.,
Gerard C.;
"Human chemotaxis receptor genes cluster at 19q13.3-13.4. Characterization of the human C5a receptor gene.";
Biochemistry 32:1243-1250(1993).
|
[7]
|
PHOSPHORYLATION AT SER-314; SER-317; SER-327; SER-332; SER-334 AND SER-338.
DOI=10.1074/jbc.270.32.19166; PubMed=7642584 [NCBI, ExPASy, EBI, Israel, Japan]
Giannini E.,
Brouchon L.,
Boulay F.;
"Identification of the major phosphorylation sites in human C5a anaphylatoxin receptor in vivo.";
J. Biol. Chem. 270:19166-19172(1995).
|
[8]
|
SULFATION AT TYR-11 AND TYR-14.
DOI=10.1084/jem.193.9.1059; PubMed=11342590 [NCBI, ExPASy, EBI, Israel, Japan]
Farzan M.,
Schnitzler C.E.,
Vasilieva N.,
Leung D.,
Kuhn J.,
Gerard C.,
Gerard N.P.,
Choe H.;
"Sulfated tyrosines contribute to the formation of the c5a docking site of the human c5a anaphylatoxin receptor.";
J. Exp. Med. 193:1059-1066(2001).
|
|
ExPASy Home page
SIB Switzerland
